Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04644770
Title A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
University of Chicago RECRUITING Chicago Illinois 60637 United States Details
Tulane School Of Medicine RECRUITING New Orleans Louisiana 70112 United States Details
XCancer Omaha / Urology Cancer Center RECRUITING Omaha Nebraska 68130 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Case Western Reserve University RECRUITING Cleveland Ohio 44106 United States Details
University of Utah Huntsman Cancer Institute RECRUITING Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field